Skip to main content
. 2020 Jul 6;25(2):587–596. doi: 10.1007/s11325-020-02086-1

Table 3.

Lung function decline between ECRHS II and ECRHS III by OSA risk (MAP index > 0.5)

Spirometry data (mean ± SD) p value
Low OSA risk (n = 3475) High OSA risk (n = 854)
Between visits 2 and 3
  Change in FEV1 (ml/year) − 41.3 ± 24.3 − 50.8 ± 30.1 < 0.001
  Difference in % predicted FEV1* − 4.50 ± 8.38 − 5.80 ± 9.50 < 0.001
  Change in FVC (ml/year) − 30.5 ± 31.2 − 45.2 ± 36.3 < 0.001
  Difference in % predicted FVC* − 0.70 ± 8.71 − 3.01 ± 9.04 < 0.001
  Difference in FEV1/FVC* − 4.93 ± 4.68 − 4.24 ± 4.66 < 0.001

Statistically significant differences (p < 0.05) indicated by italics

*Difference in percentage points